A theoretical framework to guide clinical trial design to estimate efficacies of latency-reversing agents

A theoretical framework to guide clinical trial design to estimate efficacies of latency-reversing agents

Bibliographic Details
Main Authors: R. Ke, J.M. Conway, A.S. Perelson
Format: Article
Language:English
Published: Elsevier 2015-12-01
Series:Journal of Virus Eradication
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664020313698
id doaj-bfec7de7cfb547738498a66deaa8eb14
record_format Article
spelling doaj-bfec7de7cfb547738498a66deaa8eb142021-05-04T07:25:35ZengElsevierJournal of Virus Eradication2055-66402015-12-01129A theoretical framework to guide clinical trial design to estimate efficacies of latency-reversing agentsR. Ke0J.M. Conway1A.S. Perelson2Department of Mathematics, North Carolina State University, USADepartment of Mathematics, Pennsylvania State University, USATheoretical Biology and Biophysics (T-6), Los Alamos National Laboratory, USAhttp://www.sciencedirect.com/science/article/pii/S2055664020313698
collection DOAJ
language English
format Article
sources DOAJ
author R. Ke
J.M. Conway
A.S. Perelson
spellingShingle R. Ke
J.M. Conway
A.S. Perelson
A theoretical framework to guide clinical trial design to estimate efficacies of latency-reversing agents
Journal of Virus Eradication
author_facet R. Ke
J.M. Conway
A.S. Perelson
author_sort R. Ke
title A theoretical framework to guide clinical trial design to estimate efficacies of latency-reversing agents
title_short A theoretical framework to guide clinical trial design to estimate efficacies of latency-reversing agents
title_full A theoretical framework to guide clinical trial design to estimate efficacies of latency-reversing agents
title_fullStr A theoretical framework to guide clinical trial design to estimate efficacies of latency-reversing agents
title_full_unstemmed A theoretical framework to guide clinical trial design to estimate efficacies of latency-reversing agents
title_sort theoretical framework to guide clinical trial design to estimate efficacies of latency-reversing agents
publisher Elsevier
series Journal of Virus Eradication
issn 2055-6640
publishDate 2015-12-01
url http://www.sciencedirect.com/science/article/pii/S2055664020313698
work_keys_str_mv AT rke atheoreticalframeworktoguideclinicaltrialdesigntoestimateefficaciesoflatencyreversingagents
AT jmconway atheoreticalframeworktoguideclinicaltrialdesigntoestimateefficaciesoflatencyreversingagents
AT asperelson atheoreticalframeworktoguideclinicaltrialdesigntoestimateefficaciesoflatencyreversingagents
AT rke theoreticalframeworktoguideclinicaltrialdesigntoestimateefficaciesoflatencyreversingagents
AT jmconway theoreticalframeworktoguideclinicaltrialdesigntoestimateefficaciesoflatencyreversingagents
AT asperelson theoreticalframeworktoguideclinicaltrialdesigntoestimateefficaciesoflatencyreversingagents
_version_ 1721479858356224000

Similar Items